Comments on “Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines”

Autor: Ibáñez, C., Fontanals, S., Mesia, R., Clopés, A.
Zdroj: In ESMO Open June 2023 8(3)
Databáze: ScienceDirect